Graphical Abstract Highlights d Identification of the entire murayaquinone biosynthetic gene cluster d Anthrene-type model compounds were identified from biosynthetic mutants d A linear 1(4H)-anthracenone epoxide is key intermediate for murayaquinone formation d Three oxidoreductases catalyze skeleton rearrangement of the tricyclic intermediate SUMMARY Bacterial aromatic polyketides are a group of natural products synthesized by polyketide synthases (PKSs) that show diverse structures and biological activities.
INTRODUCTION
Polycyclic aromatic polyketides are a large group of natural products that show diverse chemical structures and a broad variety of biological activities such as anticancer, antibacterial, antifungal, and antiviral. Bacterial aromatic polyketides are generally synthesized by type II polyketide synthases (PKSs). A set of enzymes called minimal PKSs, consisting of the ketosynthase heterodimer (b-keto synthase, KS a , and chain length factor, KS b ) and a free-standing acyl carrier protein (ACP), catalyze iterative Claisen condensations of ACP-tethered malonyl units to generate a highly active poly-b-ketoacyl thioester intermediate (McDaniel et al., 1994) . Associated enzymes, including ketoreductases, cyclases, and aromatases, are required to direct the shaping and folding of the nascent poly-b-ketoacyl thioester intermediate and convert it into a polyphenol intermediate with linear, angular, or discoid initial framework (Hertweck et al., 2007) . The initial frameworks may undergo oxidative rearrangements, which are often catalyzed by Baeyer-Villiger oxygenases to afford modified skeletons, for example, the transformation of dehydrorabelomycin to the heterocyclic jadomycin and gilvocarcin skeletons Tibrewal et al., 2012) . In this way an initial linear framework might also be converted into an angular one, e.g., the proposed transformation of a linear anthracycline precursor to the dioxabenzo[a]pyrene ring system of the chartreusin aglycone (Xu et al., 2005) . In addition, numerous tailoring enzymes catalyze diverse post-modification reactions, such as hydroxylations (Shen and Hutchinson, 1994; Koskiniemi et al., 2007) , epoxidations (Maier et al., 2014) , alkylations (Zhang et al., 2007) , halogenations (Zhu et al., 2013) , and glycosylations (Trefzer et al., 2000; Garrido et al., 2006) , to eventually form more complex and biologically active natural products.
Murayaquinone is an angular aromatic polyketide antibiotic initially identified from Streptomyces murayamaensis in 1986 (Sato et al., 1986) . It was subsequently isolated from several other unidentified Streptomyces species (Chu et al., 1996) . Murayaquinone shares its 9,10-phenanthraquinone core with piloquinone (Polonsky and Lederer, 1963) and haloquinone (Ewersmeyer-Wenk et al., 1981) . Early feeding experiments using isotope-labeled precursors suggested a polyketide origin of murayaquinone, derived from ten acetate units via one-step decarboxylation. The unusual incorporation pattern of sodium [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]acetate and sodium [1-13 C, 18 O 2 ]acetate allowed to propose that murayaquinone was biosynthesized from a phenanthrene intermediate via oxidative rearrangement (Gould et al., 1997; Figure 1A) .
In this work, we identified the murayaquinone biosynthetic gene cluster, and uncovered, through gene inactivation and enzyme studies, a novel biosynthetic route for the generation of angular aromatic polyketides ( Figure 1B) .
RESULTS

Heterologous Production of Murayaquinone and Its Lactone Derivatives
Streptomyces griseoruber Sgr29 was isolated from soil in the Shennongjia forest in the Hubei province of China. Its fermentation broth showed no inhibition against bacterial indicator strains, such as Staphylococcus aureus or Mycobacterium smegmatis. However, S. griseoruber Sgr29 was subjected to our library expression and analysis (LEXAS) project for activation of silent biosynthetic gene clusters of antimicrobial metabolites in a surrogate host, Streptomyces lividans SBT5 , leading to the identification of three bacterial artificial chromosome (BAC) clones (3B4, 2E12, 6F3) that endowed the host with growth-inhibitory activity against S. aureus and M. smegmatis. All three exconjugants, SBT5/3B4, SBT5/2E12, and SBT5/6F3, produced the same distinguished peaks (1, 2, and 3) in high-performance liquid chromatography (HPLC) analyses ( Figure 2A ), suggesting that the three BAC clones shared the same biosynthetic gene cluster.
A 10-L fermentation of S. lividans SBT5/3B4, referred to as the wild-type (WT) strain in this study, allowed the purification and structural elucidation of the three compounds. Based on high-resolution mass spectrometry (HR-MS) data (Table S1 ) and 1 H and 13 C nuclear magnetic resonance (NMR) data (Table  S2) , 1 and 2 were determined to be murayaquinone and murayalactone, respectively, which were previously identified from S. murayamaensis (Sato et al., 1986; Melville and Gould, 1994) . The HR-MS and NMR data suggested 3 to be an isomer of 2 (Figure 2B; Tables S1 and S2 ). Of critical importance were the assignments for C-8a and C-9a based on heteronuclear multiple bond correlation (HMBC). Correlations to C-8a (105.6 ppm) from H-5 (7.54 ppm) and H-7 (7.09 ppm) identified C-8a, which is linked to a carbonyl group. Correlation to C-9a (139.4 ppm) from H-4 (7.68 ppm) identified C-9a, which is attached to an oxygen atom (Table S2 ). The fact that compound 3 was found along with 1 and 2 indicated that it was biosynthesized in the same pathway. The structures of both 2 and 3 suggested these to be oxidative follow-up products of 1.
Identification of Essential Genes for the Biosynthesis of Murayaquinone
Sequencing of 3B4 yielded a circa 100-kb DNA region assumed to be responsible for the biosynthesis of murayaquinone, since it contained a minimal type II PKS gene set (mrqA, mrqB, and mrqC, encoding KS a , KS b , and ACP, respectively), the deletion abolished the production of murayaquinone and its lactones (Figure 2A , Dpks). Bioinformatic analysis of the sequences flanking the minimal PKS genes revealed 58 open reading frames (ORFs) related to secondary metabolism ( Figure 3A ).
To determine the essential genes for the biosynthesis of murayaquinone among these ORFs, we first determined the boundaries of mrq gene cluster by gene knockouts. Mutant Dright (removing circa 30 kb including Dorf25-28) still produced 1-3 in amounts comparable with the WT strain (i.e., SBT5/3B4) (Figure 3B) , while deletion of the adjacent gene mrqL resulted in a much higher production of 1 compared with the WT, and slightly lower production of 2 and 3 ( Figure 4 ). Thus mrqL was determined as the right boundary of the gene cluster.
The determination of the left boundary of the mrq gene cluster was more complicated. Mutants Dleft (removing 11.8 kb from orf-3 to the insert-vector boundary), Dorf-2, Dorf-1, Dorf(1-22), Dorf23, and Dorf24 still produced 1-3 in the same amounts as SBT5/3B4. However, mutant DRT (removing 8 kb from mrqT2-orf0) abolished the production of 1-3, which was unexpected ( Figure 3B ). Therefore this region, which contains two transporter genes (mrqT1 and mrqT2) and two regulatory genes (mrqR2 and mrqR3), was called the regulation region. Inactivation of mrqO8 abolished the production of 1 and significantly reduced the production of 2 and 3 ( Figure 4 ). Thus, the region between mrqO8 and mrqL was named the biosynthesis region. Therefore, the mrq gene cluster includes two regions that are separated by an insertion of about 28-kb DNA, with a transposase-encoding gene orf0 located at the left end of the insertion ( Figure 3A ).
In addition to the minimal PKS, the biosynthesis region encodes three ketoreductases (MrqF, MrqH, and MrqM), three cyclases (MrqD, MrqE, and MrqJ), eight oxidoreductases (MrqO1-O8), one regulator (MrqR1), and four hypothetic proteins (MrqG, MrqI, MrqK, and MrqL) ( Table 1) . To interrogate the genes necessary for the biosynthesis of 1-3, single-gene deletion mutants were constructed, fermented, and analyzed by HPLC. The mutants were grouped roughly according to their abilities to produce 1-3 and to accumulate related compounds ( Figures  4A-4D ). Mutants DmrqE, DmrqF, DmrqG, DmrqM, and DmrqO3 abolished the production of 1-3, and did not accumulate any metabolites related to 1, 2, or 3 ( Figure 4A ). Mutants DmrqH, DmrqI, DmrqK, and DmrqO2 still produced 2 and 3, but also accumulated either one or two anthraquinone types of compounds, compounds 4 and 5, respectively ( Figure 4B ). DmrqO4 and DmrqO5 also accumulated 4 and 5, but abolished the production of 1-3. DmrqO7 abolished the production of 1-3, and accumulated another new metabolite, compound 6, while DmrqO6 accumulated trace amounts of 5 and 6 ( Figure 4C ).
DmrqD and DmrqO8 produced only trace amounts of 2 and 3. DmrqO1 and DmrqJ still produced 1-3 ( Figure 4D ). These findings confirmed all genes that partake in the production of 1-3 within the biosynthesis region, except for mrqJ and mrqO1.
Structural Identification of the Metabolites Accumulated in the Mutants
The new peaks 4-6 were only accumulated by a few of the deletion mutants. The compounds were purified and their structures determined through MS and NMR spectroscopy. The structure of 4 was identified as mansoquinone by comparing the spectral data including HR-MS, 1 H, and 13 C NMR data with literature data ( Figure 4E ; Tables S1 and S3; Abdelfattah, 2009 ). The HR-MS of 5 suggested its molecular formula to be C 19 H 14 O 5 , with a degree of unsaturation of 13, one more than that of 4. This indicated 5 to contain either one more double bond or another ring. The 1 H and 13 C NMR data of 5 (Table S3 ) were almost identical to those of 4. One obvious difference was that the methylene at C-13 position (d H = 1.76 and d C = 17.1) of 4 was changed to a methine in 5 (d H = 4.78 and d C = 75.1), which is linked to an oxygen atom, and that 5 contained only one phenolic hydroxyl proton forming an intramolecular hydrogen bond. Furthermore, the HMBC spectrum showed a correlation of this methine proton (H-13) to the aromatic carbon C-1 (Table S3 ). Thus, 5 was identified as a derivative of 4 with C-1 linking C-13 although an oxygen bridge, thereby forming an additional pyran ring ( Figure 4E ).
The molecular formula of 6 was determined as C 19 H 18 O 6 by HR-MS, revealing that metabolite 6 contains one O atom more, but two H atoms less than 4 (Table S1 ). The 13 C-NMR spectrum of 6 (Table S3 ) showed only ten aromatic carbons, two fewer than 4, and only 2 carbonyl carbons, one fewer than 4. There were three more carbons linked to oxygen, two of these are quaternary carbons (d C = 66.5 and 68.7) and one is a methine carbon (d H = 4.98 and d C = 69.2). The methyl group, which in 4 is attached to an aromatic ring (d H = 2.37 and d C = 20.1), is in 6 attached to a saturated carbon (d H = 1.66 and d C = 16.4). All these data combined led to structure 6, which was further supported by 2D NMR spectra ( Figure 4E ; Table S3 ).
Identification of Genes Responsible for the Formation of 1 from 6
To check whether the compounds accumulated in the mutants are intermediates or shunt products in the murayaquinone biosynthetic pathway, we performed feeding experiments with compounds 4 and 6 to the Dpks mutant. We did not include 5 in these studies, because of its much different structure, which likely rendered 5 as a shunt product. When compound 4 was fed, neither 1 nor 2 nor 3 were detected by HPLC analysis ( Figure S1 ), while 1-3 were produced when 6 was fed to the same mutant ( Figure 5A ). These findings demonstrated that 4 is a shunt product, while 6 is an actual biosynthetic intermediate of murayaquinone.
The accumulation of 6 in DmrqO7 and DmrqO6 suggested that MrqO7 and MrqO6 played pivotal roles in the conversion of 6 into 1. To further determine whether other genes encode additional enzymes involved in this conversion cascade, compound 6 was fed to seven single-gene deletion mutants that abolished the production of 1-3. Compound 6 restored the production of 1-3 when fed to all of these mutants, for example the DmrqG and DmrqM mutants, except when fed to the DmrqO3 mutant ( Figure 5A ). This hinted that MrqO3 played a pivotal role in the conversion of 6 into 1, along with MrqO6 and MrqO7. Sequence analysis suggested MrqO3 to be a putative cholesterol oxidase, MrqO6 to be a putative flavin adenine dinucleotide (FAD)-dependent monooxygenase homologous to BexE, and MrqO7 to be a putative NAD(P)-dependent oxidoreductase. Note that BexE was proposed to catalyze a Baeyer-Villiger reaction in the BE-7585A biosynthesis (Jackson et al., 2016) .
Biochemical Characterization of MrqO3, MrqO6, and MrqO7 Catalyzing Conversion of 6 to 1 To uncover the mechanism of MrqO3, MrqO6, and MrqO7, which catalyze the conversion of 6 into 1, these three oxidoreductases were expressed in Escherichia coli BL21(DE3). MrqO3 and MrqO6 were purified as bright yellow proteins, revealing the presence of a flavin prosthetic group, while MrqO7 was purified as a colorless protein. LC-MS analysis of the supernatant of denatured MrqO3 and MrqO6 proved the presence of FAD ( Figure S2 ). Thereafter, we designed an in vitro assay system containing MrqO3, MrqO6, and MrqO7 in the presence of NADPH, NADH, and FAD, using 6 as a substrate. After the assay mixtures were incubated at 30 C for 60 min, 6 was completely converted to 1, whereas the control reaction with boiled enzymes did not convert 6. When any one of these three enzymes was removed from the assay, 1 was no longer detected, indicating that the cooperation of all three enzymes was essential for the conversion of 6 to 1. The presence of either NADH or NADPH in the assay gave similar conversions of 6 to 1, and 1 was not generated in absence of these co-factors, suggesting that the enzymes show no preference for NADH or Figure 2 . Production of Murayaquinone and Its Derivatives by Heterologous Expression of Three BAC Clones Containing the mrq Gene Cluster (A) Heterologous production of murayaquinone 1 and murayalactones 2 and 3 in S. lividans SBT5 containing BAC clones. Note that there was no production of 1-3 in the native strain S. griseoruber Sgr29. The pks deletion mutant (Dpks) and the vector control did not produce compounds 1-3. HPLC traces were recorded at 280 nm. (B) Chemical structures of murayaquinone 1 and murayalactones 2-3.
NADPH. However, the assay yielded similar conversions of 6 to 1 in the absence of exogenous FAD ( Figure 5B ), likely due to FAD bound to two of the proteins. Based on these findings, a time course study of the conversion of 6 to 1 catalyzed by the three enzymes was performed with 2 mM of each enzyme, 1 mM of NADPH, and 360 mM of 6. Under these conditions 6 was completely converted to 1 within 30 min. In addition, since MrqO3 is a homolog of cholesterol oxidase, we also monitored H 2 O 2 production using the Fluorimetric Hydrogen Peroxide Assay Kit. No H 2 O 2 was detected in these reactions, indicating that H 2 O 2 was not formed.
Subsequently, the sequence of events involving each enzyme was investigated. For this, the in vitro assay was changed, now using each enzyme individually in the presence of NADPH and 6. The reactions were carried out by incubation at 30 C for 30 min, and LC-MS was used to monitor the formation of possible products ( Figure 5C ). The reaction with MrqO3 did not show any conversion of substrate 6. The reaction with MrqO6 generated an obvious new ion peak at m/z 381.3 ([M + Na] + ), 16 Da more than that of 6 (365.3, [M + Na] + ), indicating one oxygen atom to be inserted into 6, resulting in structures 7 or 7 0 in Figure 6 . When MrqO7 was used in the assay, the LC-MS analysis revealed a new an ion peak at m/z 367.3 ([M + Na] + ), 2 Da more than that of 6, indicating an addition of two hydrogen atoms, consistent with a reduced product, e.g., intermediate 8.
These results indicated that both MrqO6 and MrqO7 could recognize 6 as substrate, while MrqO3 catalyzed the following last step of the conversion of 6 to 1.
To further clarify the catalytic order involving MrqO7 and MrqO6 during the conversion of 6 to 1, we carried out three parallel sequential reactions SR-I, SR-II, and SR-III. The sequential reactions were all run in a two-step manner with the MrqO7-catalyzed reduction or the MrqO6-catalyzed Baeyer-Villiger reaction separately set as alternative first steps, while MrqO3 was always involved in the following second step. After the first-step reaction, the enzyme was removed by (B) HPLC analysis of S. lividans SBT5/3B4 and its deletion mutants. Murayaquinone 1 and lactones 2 and 3 were produced by S. lividans SBT5/3B4 and all mutants except for DRT. Note: DRT was the mutant in which genes mrqT2 to orf0 were deleted. Dright, mutant in which a 30-kb fragment (including orf25-orf28) near the right boundary of the mrq gene cluster was deleted. Dleft, mutant in which an 11.8-kb fragment (from orf-3) near the left boundary of the mrq gene cluster was deleted.
filtering, which was confirmed using the Bradford Protein Assay Kit. Subsequently, the second step was initiated through addition of the other two enzymes. In SR-I, the MrqO7-catalyzed hydrogenation was set as the first-step reaction, while the MrqO6-catalyzed Baeyer-Villiger reaction was set as the first-step reaction in SR-II. The complete conversion of 6 to 1 catalyzed by all three enzymes was used as the positive control in SR-III. HPLC analysis showed that the production of 1 in SR-I was similar to that observed in the positive control, much higher than that in SR-II ( Figure S3 ). These observations unambiguously verified that the reductive epoxide opening of 6 catalyzed by MrqO7 occurs prior to the MrqO6-catalyzed Baeyer-Villiger reaction.
DISCUSSION
Bacterial aromatic polyketides are an important class of natural products because of their diverse chemical structures and bioactive properties. On the basis of the polyphenolic ring system, aromatic polyketides were classified into several different subclasses such as anthracyclines, angucyclines, and tetracyclines (Zhan, 2009 ). These natural products possess either a linear-or an angular-shaped core structure, with the exception of resistomycin and resistoflavin, which have a discoid skel- eton (Brockmann and Reschke, 1968; Brockmann et al., 1969; Ishida et al., 2006; Fritzsche et al., 2008) . The formation of the linear or angular architecture of bacterial aromatic polyketides from poly-b-keto intermediates is proposed to result from the concerted actions of minimal PKSs and associated ketoreductases, cyclases, and aromatases (Hertweck et al., 2007) . Surprisingly, several angular aromatic polyketides, such as the anticancer agent BE-7585A, the antibiotic murayaquinone, and chartreusin, displayed unexpected, atypical polyketide labeling patterns from 13 C-acetate feeding experiments (Sasaki et al., 2010; Gould et al., 1997; Canham and Vining, 1976; Canham et al., 1977) . Therefore, these angular aromatic polyketides were proposed to arise from oxidative rearrangements of linear polyphenolic intermediates, involving C-C bond cleavage and new C-C bond formation. Indeed, a linear anthracyclic metabolite, resomycin C, was accumulated upon inactivation of ChaZ, a Baeyer-Villigerase-like FAD-dependent oxygenase of the chartreusin biosynthesis. However, ChaZ was found unable to convert resomycin C (Xu et al., 2005) . In the BE-7585A biosynthetic pathway, three oxygenases (BexE, BexI, and BexM) had been proposed to catalyze the oxidative rearrangement of an unidentified linear anthracyclinone intermediate to generate an angular angucyclinone intermediate in the biosynthesis of anticancer agent BE-7585A (Sasaki et al., 2010) . Most recently, the crystal structure of BexE was resolved to 2.65 Å and used to perform docking stimulations to determine the key linear intermediate. However, unfortunately, the identification of BexE's true substrate remains challenging (Jackson et al., 2016) . In contrast, in this work on murayaquinone biosynthesis, we proved and confirmed the conversion of a linear polyphenolic intermediate to an angular aromatic polyketide.
Characterization of the mrq Gene Cluster and the Murayaquinone Biosynthetic Pathway
The entire biosynthetic gene cluster was cloned and expressed in the heterologous host S. lividans SBT5 utilizing the previously described LEXAS technology , because the natural strain S. griseoruber Sgr29 did not produce murayaquinone. The 28-kb mrq gene cluster consists of two parts, a regulation/ efflux region and a biosynthesis region, separated by an insertion of a 28-kb unrelated fragment implied to have originated horizontally (evident from the presence of a transposase gene orf0; Figure 3A ).
The murayaquinone biosynthesis pathway was updated after a bioinformatics analysis, genetic studies, and compound production from gene deletion mutants ( Figure 6A ). The generation of the first tricyclic aromatic intermediate (10) was proposed based on the typical biosynthetic logic of PKS II for the synthesis of some decaketides via C-9 ketoreduction and C-7-C-12 first ring cyclization, such as nogalonic acid (Kantola et al., 2000; Hautala et al., 2003) , tetracycline SF2575 (Pickens et al., 2009) , and mensacarcin (Maier et al., 2015) . Besides the minimal PKS, the sequences of ketoreductase MrqF, and of the two cyclases MrqE and MrqD, were highly similar to SnoaD/SsfU/ MsnO11, SnoaE/SsfY1/MsnC3, and SsfY2/MsnC2, respectively, which were responsible for the C-9 ketoreduction, C-7 to C-12 first ring cyclization, and second/third ring cyclization, respectively.
Subsequent modifications of 10, by MrqH, MrqO8, MrqI, MrqK, MrqO5, MrqO1, and MrqO4, led to the production of key intermediate 6 ( Figure 6A ). MrqH, a ketoreductase homolog, was proposed to catalyze the reduction of the keto group for the butyryl side chain formation of 11. Since the distant keto group of 10 can possibly be reduced, less effectively, by ketoreductases from the host, traces of murayaquinone and the murayalactones can be detected as products of the DmrqH mutant. However, in the absence of MrqH, 10 reacts predominantly spontaneously, initially to form a pyrone ring by cyclization and dehydration, followed by other spontaneous reactions, an oxidation to form the anthraquinone, reduction of the pyrone lactone to a hemiacetal likely through a hydrogenase from the host (McDaniel et al., 1994; Fu et al., 1994) , to eventually produce 5 ( Figure 4B) .
MrqO8 is an FAD-binding motif-containing protein showing homology to JadH that catalyzes dehydration and oxidation in the jadomycin biosynthetic pathway (Chen et al., , 2010 , so it was speculated to participate in the formation of the first aromatic ring or the conversion of 11 to 12 by dehydration (Figure 6A) . Its inactivation mutant still produced murayaquinone and murayalactones, but with drastically decreased production levels compared with the WT strain, probably due to spontaneous dehydration ( Figure 4D ). MrqI and MrqK are NTF2-like superfamily small proteins with a SnoaL_2 and SnoaL_4 domain, respectively (Marchler-Bauer et al., 2016) . The metabolic profiles of MrqI-and MrqK-inactivation mutants were very similar, except that the compound production in DmrqI was much lower. Both DmrqI and DmrqK mutants accumulated 4 and 5 while decreasing production of 2 and 3 ( Figure 4B ). Taken together, MrqI and MrqK may take part in the reduction of 12 to 13, or reduce the keto group of 15 to form the hydroxyl of 6 ( Figure 6A) .
The formation of 6 from 13 also involves three oxidation steps catalyzed by MrqO5, MrqO1, and MrqO4 ( Figure 6A ). This was proposed based on bioinformatics analysis (Table 1) and metabolic profiling of their inactivation mutants ( Figures 4C and 4D) .
Biochemical Characterization of the Conversion of the Linear Intermediate 6 to the Angular Product Murayaquinone
The accumulation of anthrene-type compounds (4, 5, and 6) in several mutants indicates that a linear anthrene-type compound, not the previously proposed angular phenanthrene, may be the true substrate of the oxidative rearrangement to form the angular murayaquinone. Biotransformation of 6 to 1 in the PKS-inactivation mutant suggested 6 to be an actual intermediate of the biosynthetic pathway of 1. Accumulation of 6 in the mrqO6 and mrqO7 deletion mutants suggested that these two genes encoded enzymes for the 6 to 1 conversion.
The enzymatic conversion of 6 to 1 was then investigated. Since both the MrqO6-and MrqO7-inactivation mutants accumulated compound 6, this compound should generally be the substrate of either MrqO6 or MrqO7. MrqO6 is an FAD-dependent monooxygenase, with 29% identity and 38% similarity to BexE, which has been proposed to catalyze a Beayer-Villiger reaction in BE-7585A biosynthesis, and MrqO7 is an NAD(P)dependent oxidoreductase. Unfortunately, when 6 was incubated with MrqO6 or MrqO7, or both MrqO6 and MrqO7, 6 was consumed and many tiny peaks were detected by HPLC ( Figure S4) , indicating unstable products, consistent with the findings for BexE and BexF (Jackson et al., 2016) , although MrqO7 shows no homology to BexF. Thus, as proposed for BexE and BexF, 6 might be converted to a very unstable compound through MrqO6 and/or MrqO7, and is readily degraded or oxidized to generate several other compounds. Therefore, we assumed that an/other enzyme/s may cooperate closely with MrqO6 and MrqO7 to convert the unstable product of MrqO6 and MrqO7 into a stable compound. But this/these enzyme/s may not accept 6 as the substrate. On the basis of this assumption, 6 was fed to the deletion mutants that did not produce 1-3, with the PKS-inactivation mutant as a positive control. This way, MrqO3, a predicted cholesterol oxidase homolog, was identified as a candidate cooperating with MrqO6 and MrqO7. Indeed, when MrqO3, MrqO6, and MrqO7 were incubated with 6 in the presence of FAD and NADPH, 6 was successfully converted to 1 within 30 min. Figure 5 . In Vivo and In Vitro Characterization of the Conversion of 6 to 1 (A) Detection of in vivo conversions in four mutants. Compound 6 was converted to 1-3 in Dpks, DmrqG, and DmrqM, but not in DmrqO3. The WT strain (SBT5/ 3B4) producing 1-3 and two mutants producing 6 (DmrqO7 and DmrqO6) were used as controls to indicate the peaks. (B) Biochemical conversion of 6 to 1 with different combinations of enzymes and co-factors. All reactions were conducted at 30 C for 60 min. The complete reaction sequence was achieved by a mixture of three enzymes (MrqO3, MrqO6, and MrqO7), three co-factors (NADPH, NADH, and FAD), and the substrate 6. Other reactions were the same mixtures as for the complete reaction sequence except for the indicated omission, for example, ÀMrqO3 means minus MrqO3 from the complete reaction mixture. HPLC traces were recorded at 280 nm. The order in which MrqO6 and MrqO7 act during the 6 to 1 conversion was determined by sequential enzymatic reactions. It was clearly demonstrated that the MrqO7-catalyzed hydrogenation on 6 is the first step, followed by the reactions of MrqO6 and MrqO3 to afford the final product 1. Some remaining questions were also addressed by these experiments: (1) MrqO6 may not interact with MrqO7 and no complex should be formed, which is different from the previous speculation (Jackson et al., 2016) ; (2) the products of MrqO7 and MrqO6 seem to be stable enough in the reaction mixture to allow the follow-up conversion steps to 1, but they readily decompose during the work-up process.
When LC-MS was used to follow the reactions catalyzed by MrqO6 and MrqO7, respectively, possible products can be detected and the type of the reactions can also be deduced from mass spectral analysis. The mass of the product 7/7 0 from MrqO6 is 16 Da greater than 6, indicating a single oxygen atom to be inserted into 6, consistent with a Baeyer-Villiger reaction, such as those proposed for ChaZ (Xu et al., 2005) or BexE (Jackson et al., 2016) . The mass of product 8 from MrqO7 is 2 Da greater than 6, and NAD(P)H is necessary for its formation, indicating that two protons were added to 6, and that the reaction catalyzed by MrqO7 is a reduction. On the basis of the nature of reductive reactions and the structure of the final product 1, we proposed that the hydride from NAD(P)H attacks C-16 to form a vicinal diol 8. The formation of 6 and 8 is probably intended to disrupt the aromatic ring and enable the Baeyer-Villiger reaction. To some extent, this may explain why the aromatic resomycin C is not a substrate of ChaZ (Xu et al., 2005) . As proposed above, the MrqO6-catalyzed Baeyer-Villiger reaction disrupts the C-C bond between C-14 and C-15 by insertion of an oxygen atom. Since C-6 cannot directly attack the carbonyl C-15 due to the spatial tension and hindrance, a thiol of a cysteine residue or a carboxyl group of MrqO6 may function as a nucleophile to attack C-15, generating an enzyme bound thioester or anhydride intermediate, as shown in Figure 6B . Thioesters are commonly used for an activation of a carboxyl carbon in PKSs and non-ribosomal peptide synthetases, the most similar example being KSs that use cysteine to load and activate the carboxyl carbons (Bisang et al., 1999; Robbins et al., 2016; Walsh, 2016) . Anhydrides are also very commonly used for carboxyl carbon activation, both chemically and enzymatically. For example, adenylation enzymes use acyl adenylation, and some amidases use acyl adenylation or phosphorylation, to activate carboxyl carbons (Begley et al., 2001; Gulick, 2009) . It is very possible that a nucleophilic residue attacks C-15 to form a linear anhydride such as 9 00 , and the electron-rich C-6 subsequently attacks the C-15 of 9 00 to form the new C-C bond of 9.
MrqO3 is a homolog of cholesterol oxidase. Cholesterol oxidases are a type of flavoenzymes that catalyze oxidation and isomerization of cholesterol in the first step of a metabolic pathway for utilizing cholesterol as a carbon and energy source (Murooka and Yamashita, 2001) . Cholesterol oxidases catalyze the oxidation of cholesterol. During this reaction, the co-factor FAD is converted to FADH 2 , which, in turn is spontaneously oxidized by aerial oxygen to generate H 2 O 2 and to recycle FAD (Yue et al., 1999; Lario et al., 2003) . In the assays catalyzed by the mentioned three enzymes, no H 2 O 2 was detected using the Fluorimetric Hydrogen Peroxide Assay Kit, suggesting that MrqO3 may catalyze oxidative and reductive reactions, accompanying the loss of two molecules of water, to eventually form the final product 1 ( Figure 6C ). First, FAD subtracts the hydride from 9 to generate FADH À and 9a. FADH À subsequently transfers the hydride to the carbonyl carbon C-15 to perform the reductive reaction to form 9b, thereby recycling FAD, distinct from the typical reactions catalyzed by cholesterol oxidases mentioned above. The loss of water of 9b is very likely catalyzed by MrqO3, but a spontaneous dehydration cannot be ruled out.
SIGNIFICANCE
Angular aromatic polyketides are a subtype of aromatic bacterial polyketide natural products. Some of these are oxidatively rearranged from initially formed linear intermediates through an FAD-dependent Baeyer-Villiger oxygenase. However, only little biochemical evidence has been obtained to support this. In this study we demonstrated, in vivo and in vitro, that three oxidoreductases cooperate to catalyze the conversion of a linear tricyclic intermediate to the angular 9,10-phenanthraquinone. In the in vitro studies, the cholesterol oxidase homolog MrqO3 played an important role to convert an unstable intermediate to a chemically stable final product. Based on the sequence alignment of the three oxidoreductases, hypotheses for an oxidative rearrangement involving a Baeyer-Villiger reaction were proposed and interrogated. Overall, the studies revealed a novel strategy for the biosynthesis of angular aromatic polyketides.
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